Patent ID: 8980922
Filing Date: 2015-03-17
Classification: A61K,A61P,C07D

Abstract:
1. A method for the treatment of a disease selected from the group consisting of Alzheimer's Disease, Parkinson's Disease-related dementia, Diffuse Lewy body-related dementia, Down syndrome-related dementia, HIV-related dementia, and depression-associated dementia in animal subjects suffering therefrom by decreasing total brain beta-amyloid peptide (Abeta) by administration of N-((1-((4-hydroxytetrahydro-2H-pyran-4-yl)methyl)piperidin-4-yl)methyl)-3-isopropyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-1-carboxamide or a pharmaceutically acceptable salt thereof to decrease total brain beta-amyloid peptide (Abeta).